Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Eirini P Papapetrou1,2,3, Axel Schambach4,5
1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Genomic safe harbors (GSHs) are crucial genome sites for predictable gene insertion. Validated GSHs are needed for gene therapy and functional genetics research.
Area of Science:
- Genomics
- Molecular Biology
- Gene Therapy
Background:
- Genomic safe harbors (GSHs) are specific genome locations that allow for the stable integration of foreign DNA.
- These sites ensure predictable transgene expression and prevent harmful alterations to the host genome.
- Currently, no fully validated GSHs are available for the human genome.
Purpose of the Study:
- To review and extend the criteria for identifying and validating GSHs.
- To discuss strategies for GSH identification and validation.
- To explore future prospects of GSH targeting in gene therapy.
Main Methods:
- Review of previously proposed GSH criteria.
- Discussion of additional considerations for GSH identification and validation.
- Analysis of recent advances in genome biology and gene targeting technologies.
Main Results:
- Proposed criteria for GSH identification and validation are discussed.
- Strategies for finding and confirming GSHs are outlined.
- The potential of GSHs for gene therapy applications is highlighted.
Conclusions:
- Validated GSHs are essential for advancing gene therapy and functional genetics.
- Further research is needed to identify and validate GSHs in the human genome.
- GSH targeting holds significant promise for diverse therapeutic applications.
More Related Videos
11:36Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus
Published on: November 20, 2016
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Related Concept Videos
Gene Therapy
Gene Therapy
What is Genetic Engineering?
In-vitro Mutagenesis
CRISPR
Transgenic Organisms
